Who Supplies Clarithromycin? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Clarithromycin exports, with 334+ registered manufacturers shipping to buyers across 144+ countries — yet a handful of companies dominate the shipments. MICRO LABS LIMITED holds the largest share at 15.4% (export value: $15.2M). Close behind, SUN PHARMACEUTICAL INDUSTRIES LIMITED (11.7%, $11.5M). CIPLA LIMITED (4.7%, $4.6M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Clarithromycin? Top Manufacturers & Their Buyers
Flow of Clarithromycin from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Clarithromycin Supplier Network — Key Market Intelligence
The Clarithromycin export market from India is led by MICRO LABS LIMITED, which alone commands a 15.4% share, shipping $15.2M worth of product across 308 shipments. The second-largest exporter, SUN PHARMACEUTICAL INDUSTRIES LIMITED, contributes $11.5M (11.7%) to the overall market. Combined, the top two suppliers alone account for 27.1% of all Clarithromycin exports, indicating a relatively concentrated supply base.
Across all 334 tracked manufacturers, the total Clarithromycin export value stands at $98.4M from 3.6K shipments. The market average shipment value is $27.5K. The single largest buyer relationship in terms of trade value is BROWN AND BURK LIMITED, receiving $11.3M worth of product.
The combined buyer network spans 24 named purchasing companies, including BROWN AND BURK LIMITED, BROWN AND BURK UK LIMITED, JSC AKRIKHIN, HATAY PHARMACEUTICAL, LABOREX UGANDA LIMIT and 19 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1MICRO LABS LIMITED
MICRO LABS LIMITED is the first-largest Clarithromycin exporter from India, with a market share of 15.4% and a total export value of $15.2M across 308 shipments. Their average shipment value of $49.3K is above the market average of $27.5K, suggesting premium or bulk contract pricing.
MICRO LABS LIMITED serves 5 named buyers in our database. BROWN AND BURK LIMITED is the dominant customer, accounting for 74.5% of this supplier's tracked business. Top customers include:
• BROWN AND BURK LIMITED — $11.3M across 229 shipments (74.5% of this supplier's total exports)
• BROWN AND BURK UK LIMITED — $2.0M across 41 shipments (13.3% of this supplier's total exports)
• JSC AKRIKHIN — $833.3K across 17 shipments (5.5% of this supplier's total exports)
• HATAY PHARMACEUTICAL — $551.4K across 11 shipments (3.6% of this supplier's total exports)
• LABOREX UGANDA LIMIT — $467.0K across 9 shipments (3.1% of this supplier's total exports)
Key Insight: MICRO LABS LIMITED's per-shipment value of $49.3K is 79% above the market average of $27.5K, consistent with large-order contracts or value-added formulations.
2SUN PHARMACEUTICAL INDUSTRIES LIMITED
SUN PHARMACEUTICAL INDUSTRIES LIMITED is the second-largest Clarithromycin exporter from India, with a market share of 11.7% and a total export value of $11.5M across 309 shipments. Their average shipment value of $37.2K is above the market average of $27.5K, suggesting premium or bulk contract pricing.
SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 5 named buyers in our database. YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN is the dominant customer, accounting for 74.4% of this supplier's tracked business. Top customers include:
• YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN — $8.5M across 230 shipments (74.4% of this supplier's total exports)
• YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN — $1.2M across 31 shipments (10.0% of this supplier's total exports)
• M/S. YUSEN LOGISTICS — $737.8K across 20 shipments (6.4% of this supplier's total exports)
• LLC RANBAXY PHARMACE — $547.9K across 15 shipments (4.8% of this supplier's total exports)
• AO RANBAXY — $511.2K across 14 shipments (4.4% of this supplier's total exports)
Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED's per-shipment value of $37.2K is 35% above the market average of $27.5K, consistent with large-order contracts or value-added formulations.
3CIPLA LIMITED
CIPLA LIMITED is the third-largest Clarithromycin exporter from India, with a market share of 4.7% and a total export value of $4.6M across 43 shipments. Their average shipment value of $106.8K is above the market average of $27.5K, suggesting premium or bulk contract pricing.
CIPLA LIMITED serves 5 named buyers in our database. CIPLA KENYA LTD C/O IMPERIAL MANAGE is the dominant customer, accounting for 70.4% of this supplier's tracked business. Top customers include:
• CIPLA KENYA LTD C/O IMPERIAL MANAGE — $3.2M across 30 shipments (70.4% of this supplier's total exports)
• ABACUS PHARMA LTD — $839.1K across 8 shipments (18.3% of this supplier's total exports)
• CIPLA KENYA LTD C/O IMPERIAL MANAGE — $241.3K across 2 shipments (5.3% of this supplier's total exports)
• HIGEN COMPANY — $164.2K across 2 shipments (3.6% of this supplier's total exports)
• ABACUS PHARMA LIMITE — $117.4K across 1 shipments (2.6% of this supplier's total exports)
Key Insight: CIPLA LIMITED's per-shipment value of $106.8K is 288% above the market average of $27.5K, consistent with large-order contracts or value-added formulations.
4WEXFORD LABORATORIES PRIVATE LIMITED
WEXFORD LABORATORIES PRIVATE LIMITED is the fourth-largest Clarithromycin exporter from India, with a market share of 3.9% and a total export value of $3.9M across 35 shipments. Their average shipment value of $110.1K is above the market average of $27.5K, suggesting premium or bulk contract pricing.
WEXFORD LABORATORIES PRIVATE LIMITED serves 5 named buyers in our database. DYVENPRO DISTRIBUCION Y VENTA DE is the dominant customer, accounting for 96.3% of this supplier's tracked business. Top customers include:
• DYVENPRO DISTRIBUCION Y VENTA DE — $3.7M across 34 shipments (96.3% of this supplier's total exports)
• DROGUERIA AMERICANA — $44.6K across 0 shipments (1.2% of this supplier's total exports)
• LABORATORIOS FARSIMA — $40.1K across 0 shipments (1.0% of this supplier's total exports)
• DROGUERIA AMERICANA — $37.0K across 0 shipments (1.0% of this supplier's total exports)
• LABORATORIOS FARSIMA — $19.1K across 0 shipments (0.5% of this supplier's total exports)
Key Insight: WEXFORD LABORATORIES PRIVATE LIMITED's per-shipment value of $110.1K is 300% above the market average of $27.5K, consistent with large-order contracts or value-added formulations.
5AUROBINDO PHARMA LTD
AUROBINDO PHARMA LTD is the fifth-largest Clarithromycin exporter from India, with a market share of 3.7% and a total export value of $3.6M across 183 shipments. Their average shipment value of $19.9K is below the market average of $27.5K, reflecting a high-volume, competitive pricing strategy.
AUROBINDO PHARMA LTD serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• AUROLOGISTICS LLC (AUROBINDO PHARMA — $1.5M across 77 shipments (42.0% of this supplier's total exports)
• RISING PHARMA HOLDINGS, INC. — $631.3K across 32 shipments (17.3% of this supplier's total exports)
• MILPHARM LIMITED — $589.7K across 30 shipments (16.2% of this supplier's total exports)
• RISING PHARMA HOLDINGS, INC. — $555.1K across 28 shipments (15.2% of this supplier's total exports)
• APL SWIFT SERVICES ( — $335.1K across 17 shipments (9.2% of this supplier's total exports)
Key Insight: AUROBINDO PHARMA LTD operates with high shipment frequency (183 shipments) at a per-shipment value of $19.9K, indicating a broad distribution network with many smaller, regular orders.
6CAPLIN POINT LABORATORIES LIMITED
CAPLIN POINT LABORATORIES LIMITED is the fifth-largest Clarithromycin exporter from India, with a market share of 2.4% and a total export value of $2.3M across 110 shipments. Their average shipment value of $21.2K is below the market average of $27.5K, reflecting a high-volume, competitive pricing strategy.
CAPLIN POINT LABORATORIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• DROGUERIA SAIMED S A — $614.3K across 29 shipments (26.4% of this supplier's total exports)
• DROGUERIA SAIMED S A — $571.1K across 27 shipments (24.5% of this supplier's total exports)
• SALDENT INTERNACIONA — $482.2K across 23 shipments (20.7% of this supplier's total exports)
• CAPLIN POINT COSTA R — $412.8K across 19 shipments (17.7% of this supplier's total exports)
• VITAFARMA S.A. — $248.9K across 12 shipments (10.7% of this supplier's total exports)
Key Insight: CAPLIN POINT LABORATORIES LIMITED operates with high shipment frequency (110 shipments) at a per-shipment value of $21.2K, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Clarithromycin Flows
Once Clarithromycin leaves the manufacturing plants of companies like MICRO LABS LIMITED and SUN PHARMACEUTICAL INDUSTRIES LIMITED, it travels to 5 destination markets with a combined import value of $98.4M. United Kingdom absorbs the largest share at 18.6% ($18.3M), followed by Belgium (11.6%) and Tanzania (8.5%).
In United Kingdom — the top destination — named importers include BROWN AND BURK LIMITED, BROWN AND BURK UK LIMITED, MEDLEY PHARMA LTD. In Belgium, key buyers are YUSEN LOGISTICS BENELUX BELGIUM, YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN.
This geographic spread reflects Clarithromycin's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Clarithromycin Go? Top Importing Countries & Their Buyers
Trade flow of Clarithromycin exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1United Kingdom
United Kingdom ranks as the first-largest destination for Clarithromycin imports from India, with a total trade value of $18.3M across 88 shipments — representing a 18.6% share of all Clarithromycin exports. The average shipment value of $207.9K is above the global average of $27.5K, indicating high-value procurement contracts or branded formulations. This market is served by 4 tracked buyers.
Named Clarithromycin importers in United Kingdom: BROWN AND BURK LIMITED is the largest buyer, accounting for 63.0% ($11.5M) of this market's total imports.
• BROWN AND BURK LIMITED — $11.5M (63.0% of United Kingdom's total)
• BROWN AND BURK UK LIMITED — $2.1M (11.7% of United Kingdom's total)
• MEDLEY PHARMA LTD — $1.1M (6.2% of United Kingdom's total)
Key Insight: United Kingdom's per-shipment average of $207.9K (656% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United Kingdom is a key market for Clarithromycin imports from India.
2Belgium
Belgium ranks as the second-largest destination for Clarithromycin imports from India, with a total trade value of $11.4M across 213 shipments — representing a 11.6% share of all Clarithromycin exports. The average shipment value of $53.4K is above the global average of $27.5K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Clarithromycin importers in Belgium: YUSEN LOGISTICS BENELUX BELGIUM is the largest buyer, accounting for 80.8% ($9.2M) of this market's total imports.
• YUSEN LOGISTICS BENELUX BELGIUM — $9.2M (80.8% of Belgium's total)
• YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN — $1.3M (11.5% of Belgium's total)
Key Insight: Belgium's per-shipment average of $53.4K (94% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Belgium is a key market for Clarithromycin imports from India.
3Tanzania
Tanzania ranks as the third-largest destination for Clarithromycin imports from India, with a total trade value of $8.4M across 28 shipments — representing a 8.5% share of all Clarithromycin exports. The average shipment value of $299.6K is above the global average of $27.5K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Clarithromycin importers in Tanzania: HEKO PHARMACY LTD is the largest buyer, accounting for 46.4% ($3.9M) of this market's total imports.
• HEKO PHARMACY LTD — $3.9M (46.4% of Tanzania's total)
• ASTRA PHARMA (T) LTD — $3.2M (38.4% of Tanzania's total)
Key Insight: Tanzania's per-shipment average of $299.6K (989% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Tanzania is a key market for Clarithromycin imports from India.
4United States
United States ranks as the fourth-largest destination for Clarithromycin imports from India, with a total trade value of $8.3M across 45 shipments — representing a 8.5% share of all Clarithromycin exports. The average shipment value of $185.5K is above the global average of $27.5K, indicating high-value procurement contracts or branded formulations. This market is served by 4 tracked buyers.
Named Clarithromycin importers in United States: AUROLOGISTICS LLC, (AUROBINDO PHARM is the largest buyer, accounting for 19.2% ($1.6M) of this market's total imports.
• AUROLOGISTICS LLC, (AUROBINDO PHARM — $1.6M (19.2% of United States's total)
• AUROLOGISTICS LLC (AUROBINDO PHARMA — $1.6M (18.8% of United States's total)
• RISING PHARMA HOLDINGS INC — $1.3M (16.0% of United States's total)
Key Insight: United States's per-shipment average of $185.5K (574% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Clarithromycin imports from India.
5Kenya
Kenya ranks as the fifth-largest destination for Clarithromycin imports from India, with a total trade value of $5.8M across 2 shipments — representing a 5.9% share of all Clarithromycin exports. The average shipment value of $2.9M is above the global average of $27.5K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Clarithromycin importers in Kenya: CIPLA KENYA LTD C/O IMPERIAL MANAGE is the largest buyer, accounting for 55.9% ($3.2M) of this market's total imports.
• CIPLA KENYA LTD C/O IMPERIAL MANAGE — $3.2M (55.9% of Kenya's total)
Key Insight: Kenya's per-shipment average of $2.9M (10411% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Kenya is a key market for Clarithromycin imports from India.
People Also Ask — Clarithromycin Supplier & Trade Network
Who are the top suppliers of Clarithromycin from India?+
Which companies buy Clarithromycin from Indian manufacturers?+
Where does Clarithromycin exported from India go?+
What is the market share of the top Clarithromycin supplier from India?+
What is the average shipment value for Clarithromycin exports from India?+
Is Clarithromycin manufactured in India and exported globally?+
Which country imports the most Clarithromycin from India?+
Who are the buyers of Clarithromycin in Belgium?+
How concentrated is the Clarithromycin supplier market in India?+
How do I find verified buyers for Clarithromycin in specific countries?+
Clarithromycin Trade Network — Key Takeaways
- 1MICRO LABS LIMITED is India's dominant Clarithromycin exporter with a 15.4% market share and $15.2M in total exports — making it the single most important sourcing entity in this market.
- 2The top 334 suppliers collectively account for 41.8% of all tracked Clarithromycin exports, with a combined trade value of $98.4M.
- 3United Kingdom is the largest destination market, absorbing 18.6% of India's Clarithromycin exports ($18.3M). Belgium (11.6%) and Tanzania (8.5%) follow.
- 4With 3.6K total shipments averaging $27.5K each, the Clarithromycin export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include BROWN AND BURK LIMITED, BROWN AND BURK UK LIMITED, YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN, YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 144 countries
Network value: $98.4M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Clarithromycin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Clarithromycin.
- 2.Flow Mapping: 334 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 3,576 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 144 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
3,576 Verified Shipments
334 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists